How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Long Term Care Pharmacy Market
- By Service Type: Medication Dispensing, Medication Therapy Management (MTM), Consultant Pharmacist Services, Specialty Pharmacy Services, Clinical Support Services
- By End User: Nursing Homes, Assisted Living Facilities, Home Healthcare, Hospice Care, Skilled Nursing Facilities
- By Distribution Channel: Retail Pharmacies, Mail Order Pharmacies, Specialty Pharmacies, In-house Pharmacy Services
- By Drug Type: Generic Drugs, Branded Drugs, Specialty Drugs, Over-the-Counter (OTC) Drugs
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Medication Dispensing leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.166 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.174 →
Full report · locked preview
Everything inside the Long Term Care Pharmacy Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Omnicare (a CVS Health company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →PharMerica
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BrightSpring Health Services
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Guardian Pharmacy Services
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Avella Specialty Pharmacy
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Option Care Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Medly Pharmacy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Capsa Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →ScriptPro
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →CareMax Pharmacy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →PillPack (an Amazon company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →CareCentrix
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Lincare Holdings
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Enclara Pharmacia
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Fresenius Kabi
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Medication Dispensing42.8
- Medication Therapy Management (MTM)14.9
- Consultant Pharmacist Services16.7
- Specialty Pharmacy Services14.6
- Clinical Support Services11.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Omnicare (a CVS Health company)22.4
- PharMerica24.6
- BrightSpring Health Services6.0
- Guardian Pharmacy Services5.5
- Avella Specialty Pharmacy9.5
- Option Care Health4.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.7
- Europe23.0
- Asia Pacific20.4
- Latin America14.7
- Middle East and Africa10.2
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Omnicare (a CVS Health company) | 75 | 91 | 75 | 73 | 77 | 95 | 81 |
| PharMerica | 75 | 83 | 77 | 81 | 92 | 72 | 80 |
| BrightSpring Health Services | 70 | 81 | 71 | 74 | 86 | 68 | 75 |
| Guardian Pharmacy Services | 68 | 77 | 76 | 79 | 72 | 61 | 72 |
| Avella Specialty Pharmacy | 72 | 72 | 54 | 68 | 75 | 75 | 69 |
| Option Care Health | 70 | 60 | 63 | 71 | 53 | 69 | 64 |
| Medly Pharmacy | 48 | 56 | 59 | 43 | 49 | 58 | 52 |
| Capsa Healthcare | 36 | 44 | 57 | 39 | 38 | 48 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Omnicare (a CVS Health company)
- PharMerica
- BrightSpring Health Services
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Omnicare (a CVS Health company) | ✓ | ◐ | ✓ | − | ◐ | ✓ |
| PharMerica | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| BrightSpring Health Services | − | ◐ | − | ✓ | ✓ | − |
| Guardian Pharmacy Services | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Avella Specialty Pharmacy | ◐ | ✓ | − | ✓ | ◐ | ◐ |
| Option Care Health | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Medly Pharmacy | − | − | ◐ | − | − | − |
| Capsa Healthcare | − | ◐ | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger3
Strong scale, closing on the leaders.
Contender1
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Service Type in North America, then scale across Long Term Care Pharmacy Market — a $528M beachhead inside a $8.73B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Medication Dispensing
Best fit — highest urgency & budget in Service Type.
Medication Therapy Management (MTM)
Strong fit — clear ROI and a fast path to value.
Consultant Pharmacist Services
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Distribution Channel
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Long Term Care Pharmacy Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Long Term Care Pharmacy Market is a high-growth opportunity — $2.29B by 2033, compounding at 11.4%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.4% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Long Term Care Pharmacy Market — a $4.36B market by 2033. Plan: grow share from 9.7% to 15.7%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.7% | 15.7% | At risk |
| Revenue | $422M | $684M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 33.4% | 44.3% | On track |
| Customer retention | 90.7% | 94.0% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $71M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentOn track
Sales deck · value proposition
Win the Long Term Care Pharmacy Market conversation — a $4.14B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Long Term Care Pharmacy Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Long Term Care Pharmacy Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Long Term Care Technology Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportLong Term Evolution (LTE)Technology Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportLong Term LNG Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportLong Wave Radar Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportLong Working Distance Objectives for Semiconductors Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportLong-acting GLP-1RA Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportLong-Acting Injectable Antipsychotics Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportLong-Acting Insulin Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportLong-acting Muscarinic Antagonist (LAMA) Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportLongan Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportLongan Tincture Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportLongdan Xiegan Pills Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy